meta_pixel
Tapesearch Logo
Log in
Squawk on the Street

S&P 500's Record Rally, Meta's $65B AI Investment Plan, Novo Nordisk's Obesity Drug Boost 1/24/25

Squawk on the Street

CNBC

Business, News, Investing

4.1567 Ratings

🗓️ 24 January 2025

⏱️ 41 minutes

🧾️ Download transcript

Summary

Transcript

Click on a timestamp to play from that location

0:00.0

It's Jim Kramer here. You're listening to the opening bell of CBC's Squawk on the Street. Don't miss a minute of the action. Good Friday morning. Welcome to Squawk on the Street. I'm Carl Kintanillo with Jim Kramer, David Fabry, post-9 of the New York Stock Exchange. Bulls look to build on Thursday's all-time high, the first new high of the year, as the tension also turns to Bank of Japan hiking rates and the

0:21.6

president now jawboning the Fed, OPEC, and the banks. Roadmap begins with the movers in the

0:27.5

markets. Two Dow stocks, Amex and Verizon crossing the tape this morning. Major averages still on track

0:32.5

for the second positive week in a row. Plus back to the weight loss drug, boom, shares in

0:37.1

Nova Nordisk are rallying.

0:39.0

This as a new obesity drug, its testing shows significant weight loss. It's early trial results,

0:43.9

though. And we're keeping an eye on one of the biggest energy IPOs we've seen in a decade.

0:48.8

Venture Global, America's second largest LNG exporter is set to make a debut right here at the NYC.

0:55.6

Let's begin with the markets this morning in this S&P record run, Jim, over the last week

1:00.2

and a half, best eight session rally since August, although not as broad as it was last year.

1:06.7

No, but I do like to see that this is a rally that's not led by Apple.

1:10.5

It's a rally. It's not led by Nvidia.

1:12.8

It's a rally where Microsoft seems to be tepid, alphabet kind of here and or there.

1:17.9

Tesla, you have to reignite it with an Adam Jonas piece talking about an ETF of AI.

1:24.6

But you'll see these beautiful one-off moves. Union Pacific, Great Quarter, versus, say, CSX.

1:30.9

Or how about the drugs? How about the drugs? I mean, last week, I was at the JP Morgan Healthcare Conference.

1:36.5

Yeah.

1:37.3

And no one liked the drugs? They're exploding yesterday. So what I'm saying is, is that many bull markets each day. Banks had a bull market, drugs had a bull market, rails had a bull market. It's like, I love it. Wheats had a bull market. This is what I want. Not brought them one day, but brought a multiple. Over time. Over time. It's what you want. Yes. Because it what creates a healthy market, so to speak. Well, that's kind of what I'm saying. I'm just reiterating what it is you're saying and trying to understand why. I just don't want it to be the same old, same old. Like today there's a piece in the FT. I like the FTA. But they were talking about, you know, now things are really stretched. If it's saying when a Mag 7, no, it's not a mag seven rally for heaven's sick it's not and

2:18.5

people worried about Microsoft and clippy two you know benny off taking a shot at them

2:22.5

i'm not hearing anything any real mojo for about alphabet i mean apple we have another

2:27.6

guy today trim price target i mean invidia can't get out of the 146 way. I just...

2:35.0

Okay.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.